-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ck26KNuAjDYEO+cuoK+IeTSKz+dBTi1tv7mRS6TEApflrTOW5G5Z9IVZm1fKfArU Gy7HcnG5Ui/GVVZexJxTYA== 0000912057-99-006769.txt : 19991119 0000912057-99-006769.hdr.sgml : 19991119 ACCESSION NUMBER: 0000912057-99-006769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19991031 FILED AS OF DATE: 19991118 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 001-12584 FILM NUMBER: 99760439 BUSINESS ADDRESS: STREET 1: 425 WOODSMILL RD CITY: ST LOUIS STATE: MO ZIP: 63017 BUSINESS PHONE: 3145799899 MAIL ADDRESS: STREET 1: 425 WOODSMILL RD CITY: ST LOUIS STATE: MO ZIP: 63017 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19940606 COMPANY DATA: COMPANY CONFORMED NAME: DAVIS TODD CENTRAL INDEX KEY: 0001098912 STANDARD INDUSTRIAL CLASSIFICATION: [] DIRECTOR FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: C/O ELAN INTERNATIONAL SERVICES LTD STREET 2: 102 ST JAMES COURT FL04 CITY: SMITHS PARISH BERMUD MAIL ADDRESS: STREET 1: C/O ELAN INTERNATIONAL SERVICES LTD STREET 2: 102 ST JAMES COURT FL04 FLATTS SMITHS CITY: PARISH BERMUDA 4 1 4
- -------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION ----------------------------- FORM 4 WASHINGTON, D.C. 20549 OMB APPROVAL - -------- ----------------------------- / / CHECK THIS BOX IF NO STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB NUMBER: 3235-0287 LONGER SUBJECT TO EXPIRES: FEBRUARY 1, 1994 SECTION 16. FORM 4 OR Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, ESTIMATED AVERAGE BURDEN FORM 5 OBLIGATIONS MAY Section 17(a) of the Public Utility Holding Company Act of 1935 or HOURS PER RESPONSE .... 0.5 CONTINUE. SEE Section 30(f) of the Investment Company Act of 1940 ----------------------------- INSTRUCTION 1(b). (Print or Type Responses) - ------------------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name AND Ticker or Trading Symbol 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner DAVIS TODD C. Sheffield Pharmaceuticals, Inc. (SHM) ---- ---- - --------------------------------------------------------------------------------------------- Officer (give Other (Last) (First) (Middle) 3. IRS or Social Security 4. Statement for ---- title ---- (specify Number of Reporting Month/Year below) below c/o Elan Pharmaceutial Research Corp. Person (Voluntary) ----------------- ------------------ 1300 Gould Drive October 1999 - -------------------------------------------- --------------------- 7. Individual or Joint/Group Filing (Street) 5. If Amendment, (Check Applicable Line) Date of Original ___Form filed by One Reporting Person (Month/Year) ___Form filed by More than One Gainesville Florida 30504 Reporting Person - ------------------------------------------------------------------------------------------------------------------------------------ (City) (State) (Zip) TABLE I - NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED - ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature (Instr. 3) action action or Disposed of (D) Securities ship of In- Date Code (Instr. 3, 4 and 5) Beneficially Form: direct (Instr. 8) Owned at Direct Bene- (Month/ End of (D) or ficial Day/ ------------------------------------------- Month Indirect Owner- Year) (A) or (I) ship Code V Amount (D) Price (Instr. 3 (Instr. 4) (Instr. 4) and 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $.01 per share June 30, 1998 P (2) 4,571,428 I (3) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
FORM 4 (CONTINUED) TABLE II - DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) - ------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative Security 2. Conver- 3. Trans- 4. Transac- 5. Number of Deriv- 6. Date Exer- (Instr. 3) sion or action tion Code ative Securities Ac- cisable and Ex- Exercise Date (Instr. 8) quired (A) or Dis- piration Date Price of (Month/ posed of (D) (Month/Day/ Deriv- Day/ (Instr. 3, 4, and 5) Year) ative Year) Security -------------------- Date Expira- -------------------------------------- Exer- tion cisable Date Code V (A) (D) - ------------------------------------------------------------------------------------------------------------------------ Director Options 1.4375 9/15/98 P 25,000 3/15/99 9/15/03 - ------------------------------------------------------------------------------------------------------------------------ Director Options 2.3125 1/1/99 P 15,000 7/1/99 1/1/04 - ------------------------------------------------------------------------------------------------------------------------ Series D Preferred Stock $4.86 10/18/99 P 12,015 10/18/01 10/18/05 - ------------------------------------------------------------------------------------------------------------------------ Series F Preferred Stock $3.40 10/18/99 P 5,000 10/18/01 10/18/05 - ------------------------------------------------------------------------------------------------------------------------ Warrant $6.00 10/18/99 P 150,000 10/18/02 10/18/06 - ------------------------------------------------------------------------------------------------------------------------ Warrant $2.00 6/30/98 P 990,000 12/31/98 6/30/05 - ------------------------------------------------------------------------------------------------------------------------ Series C Convertible Preferred Stock $1.41 6/30/98 P 11,500 6/30/98 6/30/08 - ------------------------------------------------------------------------------------------------------------------------ Convertible Promissory Note $1.75 6/30/98 P N/A 6/30/05 - ------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative Security 7. Title and Amount of Under- 8. Price 9. Number 10. Owner- 11. Nature (Instr. 3) lying Securities of of Deriv- ship of In- (Instr. 3 and 4) Deriv- ative Form direct ative Securi- of De- Bene- Secur- ties rivative ficial ity Bene- Secu- Own- (Instr. ficially rity: ership 5) Owned Direct (Instr. 4) at End (D) or Amount or of Indi- Title Number of Month rect (I) Shares (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------ Director Options Common Stock 25,000 N/A 25,000 D - ------------------------------------------------------------------------------------------------------------------------------ Director Options Common Stock 15,000 N/A 15,000 D - ------------------------------------------------------------------------------------------------------------------------------ Series D Preferred Stock Common Stock 2,472,222 $12,015,000 12,015 I (3) - ------------------------------------------------------------------------------------------------------------------------------ Series F Preferred Stock Common Stock 1,470,588 (1) 5,000 I (3) - ------------------------------------------------------------------------------------------------------------------------------ Warrant Common Stock 150,000 (1) N/A I (3) - ------------------------------------------------------------------------------------------------------------------------------ Warrant Common Stock 990,000 (2) N/A I (3) - ------------------------------------------------------------------------------------------------------------------------------ Series C Convertible Preferred Stock Common Stock 8,904,965 $11,500,000 12,556 I (3) - ------------------------------------------------------------------------------------------------------------------------------ Convertible Promissory Note Common Stock 1,209,485 N/A N/A I (3) - ------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: (1) The Shares of Series F Preferred Stock and the Warrant issued on /s/ Todd Davis November ,1999 October 18, 1999 were purchased by Elan International Services, Ltd. ------------------------------- ---------------- ("EIS") for aggregate consideration of $5,000,000. **Signature of Reporting Person Date (2) The Shares of Common Stock and the Warrant issued on June 30, 1998 were purchased by EIS for aggregate consideration of $6,000,000. (3) Elan Pharmaceuticals Investments Ltd. ("EPIL") is the record and beneficial owner of the securities purchased on June 30, 1998. EIS is the record and beneficial owner of securities purchased on October 18, 1999. EIS and EPIL are each wholly-owned subsidiaries of Elan Corporation, plc, an Irish public limited company. The reporting person is Director of Planning, Investments and Development of Elan Pharmaceuticals Research Corp., an affiliate of EIS and EPIL. **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Page 2 of 3 SEC 1474 (3/91)
-----END PRIVACY-ENHANCED MESSAGE-----